City of Hope

City of Hope, a NCI-designated Comprehensive Cancer Center

Endocrine and breast cancer surgeon joins City of Hope as associate professor of surgery

Skip Navigation

Global Navigation

 Quick Links

Endocrine and breast cancer surgeon joins City of Hope as associate professor of surgery 

 


Contact: Roberta Nichols
800-888-5323
ronichols@coh.org


DUARTE, Calif., September 22, 2008 – John Hosei Yim, M.D., a nationally recognized expert in endocrine and breast cancer research and treatment, has been appointed associate professor of surgery at City of Hope. Yim specializes in treating patients with breast and endocrine tumors, including those of the thyroid, parathyroid and adrenal glands. He also conducts scientific research into interferon regulatory factors – proteins that have been shown to kill breast and other cancer cells. He joins City of Hope from the University of Pittsburgh’s Department of Surgery, where he was an assistant professor of surgery.

“Dr. Yim’s expertise in breast and endocrine cancers will be an invaluable resource for City of Hope,” said Joshua D. I. Ellenhorn, M.D., chief, Division of General Oncologic Surgery at City of Hope.

“While at the University of Pittsburgh, he helped establish a training program for endocrine surgeons,” continued Ellenhorn. “With increases in endocrine cancers such as thyroid cancer, there is an urgent need for surgeons trained in this specialty.”

A fellow of the American College of Surgeons, Yim belongs to numerous professional and scientific societies, including the American Association of Endocrine Surgeons and the American College of Surgeons’ Oncology Group, where he was a member of the Endocrine Oncology Working Group and the Ethics Committee. His research has been published in major medical and scientific journals, including Surgery, Annals of Surgery, Oncogene, Journal of Immunology and Cancer Research.  His work has been funded by the National Cancer Institute, the Susan G. Komen Breast Cancer Foundation, and the Department of Defense Breast Cancer Research Program. He has been named as one of the Best Doctors in America by Best Doctors Inc., as well as a top surgeon by the Consumers’ Research Council of America. 

Yim obtained his medical degree from Stanford University School of Medicine, and his bachelor’s degree in molecular biophysics and biochemistry from Yale University. He completed his surgical internship and residency at Barnes-Jewish Hospital in St. Louis, and a surgical research fellowship at Washington University School of Medicine, in St. Louis.

About City of Hope 

City of Hope is a leading research, treatment and education center for cancer, diabetes and other life-threatening diseases. Designated as a comprehensive cancer center, the highest honor bestowed by the National Cancer Institute, and a founding member of the National Comprehensive Cancer Network, City of Hope's research and treatment protocols advance care throughout the nation. City of Hope is located in Duarte, Calif., just northeast of Los Angeles, and is ranked as one of "America's Best Hospitals" in cancer by U.S.News & World Report. Founded in 1913, City of Hope is a pioneer in the fields of bone marrow transplantation and genetics. For more information, visit www.cityofhope.org or follow City of Hope on Facebook, Twitter, YouTube or Flickr. Learn more >>

 Search

Go!
Advanced Search Options
News & Publications Search
NCI CCC LogoCity of Hope is one of 40 Comprehensive Cancer Centers, the highest designation bestowed by the National Cancer Institute and a recognition of excellence in cancer treatment, research, prevention and education.
City of Hope strongly supports and values the uniqueness of all individuals and promotes a work environment where diversity is embraced.
NCI CCC LogoThe National Comprehensive Cancer Network®
(NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HON code of the Healthcare on the Net Foundation.